• News
  • SAN DIEGO
  • BioTech

DexCom cited as bellwether

CNBC stock commentator Jim Cramer on Friday cited San Diego’s DexCom Inc. (Nasdaq: DXCM) as a bellwether for the stock market, which should go into a turnaround on Wall Street within the next year.

To continue reading, subscribe now
or
log in to your account
User Response
0 UserComments

Dexcom Inc.

Company Website

5555 Oberlin Drive
San Diego, CA 92121

Company Trade Data

Stock Symbol Close
Change
Chg %Chg
Volume
52-Week
High Low
DXCM
55.74
  2.48  
+ 4.66%
556,103,000
58.32
28.09

Insider Trade Data

Date Insider Shares Type Value
12/12/2014 Sayer, Kevin R 10,000 Sell $539,700
12/11/2014 Balo, Andrew K 10,000 Sell $554,195
12/11/2014 Balo, Andrew K 10,000 Exchange $76,300
12/08/2014 Valdes, Jorge A 16,000 Sell $896,509
12/08/2014 Valdes, Jorge A 16,000 Exchange $116,000

Dexcom Inc. Executive(s):

Terrance Gregg

  • Chief Executive Officer, Director

Kevin Sayer

  • Director, President

Patrick Murphy

  • Assist. General Counsel

Similar Companies

NAICS - -
Subscribe Today!